Overview
McDermott Will & Schulte advised François Moisson and Frédéric Paqueville, founders of Excelya, one of France’s leading CROs (Contract Research Organisations), on Eurazeo’s acquisition of a stake in the company alongside its management team.
Through this transaction, Excelya aims to accelerate its European expansion, particularly through targeted external growth. The Group’s ambition is to become the European leader in clinical research, positioning itself as the preferred partner of medium-sized European pharmaceutical companies.
The McDermott Will & Schulte team on this transaction was composed of:
Corporate
Grégoire Andrieux, Partner
Côme Wirz, Counsel
Maud Moriceau, Associate
Tax
Antoine Vergnat, Partner
Fanny Le Pogam, Associate
Financing
Stanislas Chenu, Associate
Clarisse de Roux, Associate
About Us
Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.